ArticleMedical physics2026
Study of prompt gamma and neutron emission for real-time range verification in proton and carbon-ion therapy.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAccurate range verification is crucial in hadrontherapy to fully exploit the ballistic advantages of charged particles and prevent damage to healthy tissues. Among the proposed approaches, prompt gamma imaging (PGI) has emerged as an effective technique for real-time monitoring, but its performance is limited by the intense neutron background generated during irradiation, especially with carbon-ions. PURPOSE: This work presents a Monte Carlo study performed with the FLUKA code to investigate prompt gamma and neutron emission in proton and carbon-ion therapy. A prototype detection system based on a knife-edge collimator coupled to a pixelated LYSO scintillator was simulated to evaluate its capability for range verification. The aim is to quantify how neutron fields and neutron induced signals bias or degrade range related quantities, and how these effects differ between proton and carbon-ion beams.
methodsThe analysis includes the characterization of prompt gamma energy spectra and spatial profiles, the assessment of neutron fields within a treatment room, and the decomposition of the detector signal into primary gammas, secondary gammas, and neutrons.
resultsResults show that prompt gamma profiles correlate well with the Bragg peak position, particularly within the 3-7 MeV energy window, while carbon ions exhibit higher prompt gamma yields but also significantly stronger neutron backgrounds compared to protons. Detector simulations highlight the impact of neutron capture on lutetium, producing distinct peaks that must be accounted for in the detector signal analysis. The fall-off retrieval precision (FRP) analysis indicates that the distal fall-off of prompt gamma profiles can be used to estimate the Bragg peak position, while secondary radiation components introduce additional fluctuations that affect the achievable precision, particularly for carbon-ion beams.
conclusionsThe study provides a detailed characterization of prompt gamma and neutron contributions in proton and carbon-ion therapy and highlights the main physical factors affecting PGI-based range monitoring, particularly in the presence of neutron-induced backgrounds. These results provide useful insights for the design and optimization of prompt gamma detection systems in clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.